Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma. [electronic resource]
Producer: 19990415Description: 119-25 p. digitalISSN:- 0169-5002
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cisplatin -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Mesothelioma -- drug therapy
- Middle Aged
- Pleural Neoplasms -- drug therapy
- Recombinant Proteins
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.